Guardian Pharmacy Services, Inc. (GRDN): Cost of Revenue

Annual figures by period end, from SEC filings.

$1.16B

Year ended 2025-12-31

$1.15B

Trailing 12 months to 2026-06-30

2024-12-31 Cost of Revenue (USD) 2025-12-31

Period ended	Cost of Revenue	Change YoY	Source filing
2025-12-31	$1.16B	+17.5%	2026-03-11, From 2025-01-01
2024-12-31	$984.04M	n/a	2026-03-11, From 2024-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Retail-Drug Stores and Proprietary Stores), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cost of Revenue	Change YoY
Guardian Pharmacy Services, Inc. (GRDN)	2025-12-31	$1.16B	+17.5%
PetMed Express Inc (PETS)	2025-03-31	$157.84M	-16.6%
Ridgetech Inc. (RDGT)	2026-03-31	$127.41M	+9.7%
CVS Health Corp (CVS)	2025-12-31	$221.17B	+7.2%

Compare GRDN, PETS, RDGT, CVS side by side · Screen every company in Retail-Drug Stores and Proprietary Stores ↗